There is a general consensus among clinicians that a serum prostate-specific antigen (PSA) level ≥4.0 ng/ml is predictive of prostate cancer, and necessitates a biopsy. But there is a dearth of ...

To perform prostate cancer biopsies, doctors use a technology called MRI fusion-guided biopsy. This technique combines MRI with a transrectal ultrasound to more precisely sample prostate tissue ... 46 ...

Targeted biopsy only (ignoring systematic samples ... whom underwent prostate biopsy. The patients had a median age of 65 and median prostate-specific antigen (PSA) level of 6.9 ng/mL.

A transperineal biopsy is a needle biopsy to look for cancer cells in the prostate. This helps to diagnose prostate cancer. Your doctor puts a needle into the prostate through the skin behind the ...

in blood samples. Prostate cancer spreads by shedding CTCs into the bloodstream, so higher counts in blood generally reflect worse disease. Sometimes referred to as a liquid biopsy, the CTC assay ...

This score helps your doctor decide on the next step and whether you need to have a biopsy. This is where your doctor takes a sample of your prostate gland. This score is called the Likert or PI-RAD ...

Several biomarker tests have been available for over a decade, with extensive research backing their effectiveness. Yet, many ...

Nearly all men with a polygenic risk score in the 90th percentile or above had a 10-year absolute risk for prostate cancer exceeding 3.8%. A polygenic risk score (PRS) identifies more patients with ...